Mr. Suhail Al Ansari

With over 18 years of experience in the healthcare industry, Suhail along with being the Deputy Vice Chairman of Gawah Holdings is the founder and managing partner of Biolinka, an investment management advisory and holding company focused on growth stage innovative companies in the healthcare industry, with imminent or existing regulatory approvals, but limited market deployment, to fuel their growth on a global scale.

In addition to successfully investing in medical technology companies, Biolinka also provides boutique advisory services to clients in the USA, UK, Europe and Singapore, partnering with renowned global academic and healthcare institutions to increase market access for their businesses, develop business opportunities, optimize operations, commercialize products and develop strategic growth plans.

In addition to his focused role at Biolinka, Suhail serves as an Advisory Board member at i-OTA, a boutique financial advisory firm that is a part of Gawah Holdings, based in the UAE. He also advises numerous multinational healthcare companies and academic medical institutions spanning from North America to Asia. Prior to Biolinka and Gawah Holdings, Suhail formerly led the Healthcare Unit at Mubadala Investment Company as Executive Director of Healthcare. As founder of the healthcare practice at Mubadala, his primary responsibilities were to oversee the development, operations and management of the healthcare assets and initiatives within the company’s portfolio.

During his tenure at Mubadala, Suhail established and oversaw the operations of eight healthcare businesses with globally renowned partners such as the Cleveland Clinic, Laboratory Corporation of America and Imperial College London, managing a portfolio worth over US$ 4B in assets with 6,000 employees and annual turnover exceeding US$ 750M.

Prior to Mubadala, Suhail worked with Dubai Holding as head of Marketing & Communications at Dubai Healthcare City. He was seconded to Dubai Holding from the Executive Office of the Crown Prince of Dubai, where he was member to the Strategy department.

Suhail has held numerous board positions including Chairman of the Board of Directors of The Imperial College London Diabetes Centre, Healthpoint Hospital, National Reference Laboratory, Tawam Molecular Imaging Centre, Capital Health Screening Centre, Abu Dhabi Telemedicine Centre, Viceroy Hotels and Resorts and Agility Abu Dhabi. He was also Vice Chairman of the Board Directors of Cleveland Clinic Abu Dhabi.

In addition to his healthcare specific roles, he was also the Secretary General of the Abu Dhabi – Singapore Joint Forum, an initiative created by the Executive Affairs Authority of Abu Dhabi and government of Singapore to facilitate government and private sector collaboration between Singapore and Abu Dhabi.

Suhail holds a Masters of Science degree in Finance from Boston College, USA, and a Bachelors of Engineering in Environmental Chemical Engineering from the University of Surrey, UK.